Through the skin, or under it — that is the whole distinction. Morpheus8 presses an array of insulated needles into the skin and releases radiofrequency from the last half-millimetre of each one. FaceTite passes a cannula beneath the skin through a small entry point and runs current between that tube and an electrode on the surface above it. Same company, same energy, two different procedures.
The practical consequences follow directly. Morpheus8 uses topical numbing cream and leaves the skin intact. FaceTite involves an entry point and, in the published case series of this technique, local anaesthesia. If your clinic offers both and describes them in the same breath, that is the sentence to ask about first.
They are frequently sold as one combined treatment, and the evidence for combining them is not a human trial. The pairing is described in a 2019 technique paper that covers Morpheus8 together with FaceTite and BodyTite. The journal graded it Level 4 evidence - a technique description and case experience, not a controlled comparison. The only published study that put a Morpheus8 group, a radiofrequency-under-the-skin group and a combined group side by side was a 24-rat histopathology study — and it used BodyTite, the body version, not FaceTite. Combining them is clinic practice with a plausible rationale, not a tested protocol.
Neither one is cleared for a cosmetic use. Morpheus8's clearances read electrocoagulation and hemostasis — surgical language for sealing tissue and stopping bleeding — in December 2019 (K192695), then coagulation or contraction of soft tissue in July 2023 (K231790). FaceTite is not the name on any FDA clearance at all; it is a handpiece under InMode's general RF System clearances, worded the same way. Jowls, laxity, tightening and contouring appear in neither. Off-label treatment is legal and normal — it just means no regulator reviewed either device for the thing you are being sold.
The pins are insulated except the distal 0.5 mm, so heat leaves at the needle tip rather than at the surface.
Temperature and tissue resistance are monitored and the energy adjusts automatically as the cannula moves.
The deepest figure in any FDA summary is 7.0 mm. "8 mm" is a 2020 marketing number — 7 mm of needle plus 1 mm of thermal profile — and depth is not something the FDA clears.
No cannula length or gauge is published, so none is quoted.
Above 62 mJ per pin the applicator is limited on-label to skin types I to IV.
No 510(k) exists under the name FaceTite.
Those figures come from RF microneedling studies on other manufacturers' machines, not from Morpheus8 itself.
No published trial gives a recovery figure for FaceTite, so none is quoted. It is a procedure with an entry point and an anaesthetic, which is a different order of event.
Clinics commonly package these together, usually as FaceTite for the deeper layer and Morpheus8 for the skin above it. The mechanical logic is easy to follow, and the two really do act at different depths.
What is missing is a controlled human study. The published support amounts to a technique paper the journal graded Level 4 - a technique description and case experience - and an animal study using the body version of the device. No published study measures whether people who have both do better than people who have one — or whether the combined heat load raises the risk of anything.
That is not a reason to refuse. It is a reason to ask the clinic what they expect the second device to add, and to be sceptical of a price that assumes both are necessary.
Morpheus8 has one dated, citable price figure and it comes from consumers, not a survey. RealSelf's Morpheus8 cost page, last updated 10 May 2024, gives an average of $1,861 drawn from 124 patient-reported prices, notes prices starting at $549 for a single session on one small area, and says a full series can cost upwards of $4,000. Those are self-reported, unaudited, not a random sample, US-skewed and now dated.
No professional society publishes a price for this treatment. The American Society of Plastic Surgeons stopped reporting minimally invasive physician fees after its 2023 report, and the categories it did publish were not RF microneedling.
There is no reliable published price for FaceTite, so none is quoted. Ask for the total course price, ask what the tips and consumables cost, and ask what is included if a second pass is needed.
If you get cold sores, say so when you book — not on the day. Antiviral medicine is started in advance, so it has to be prescribed before the appointment. There is no published data on cold-sore reactivation after these treatments specifically; the precaution is carried over from laser resurfacing, where reactivation is well documented and prophylaxis is standard.
Also disclose a pacemaker or an implantable defibrillator, and any metal implant near the treatment area. These are labelled contraindications for radiofrequency devices generally. They are precautionary rather than tested — no published study has treated patients with cardiac implants — so the people to advise you are your cardiology team, not the clinic's front desk.
Say too if you have an active skin infection in the area, a history of raised or thickened scarring, or any current or past skin cancer where you are being treated.
These are signs of an infection that is spreading, and they need urgent care rather than a wait-and-see appointment.